CSS
KYNB

Cubist Systematic Strategies’s Kyntra Bio KYNB Stock Holding History

Cubist Systematic Strategies’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-11,493
Closed -$256K – 3139
2024
Q2 		$256K Buy
11,493
+11,206
+3,905% +$346K ﹤0.01% 2418
2024
Q1 		$16.9K Buy
287
+195
+212% +$8.4K ﹤0.01% 3484
2023
Q4 		$2.04K Hold
92
– – ﹤0.01% 3452
2023
Q3 		$1.98K Sell
92
-553
-86% -$21.7K ﹤0.01% 3205
2023
Q2 		$43.5K Buy
+645
New +$267K ﹤0.01% 3109
2022
Q3 		– Sell
-13
Closed -$4K – 4512
2022
Q2 		$4K Sell
13
-1,872
-99% -$478K ﹤0.01% 4303
2022
Q1 		$566K Buy
1,885
+24
+1% +$8.37K ﹤0.01% 2453
2021
Q4 		$656K Sell
1,861
-7,401
-80% -$2.3M 0.01% 2238
2021
Q3 		$2.37M Buy
9,262
+8,922
+2,624% +$3.16M 0.03% 899
2021
Q2 		$227K Sell
340
-401
-54% -$231K ﹤0.01% 2481
2021
Q1 		$643K Buy
741
+510
+221% +$543K 0.01% 1813
2020
Q4 		$214K Sell
231
-1,713
-88% -$1.8M ﹤0.01% 2208
2020
Q3 		$2M Sell
1,944
-684
-26% -$736K 0.03% 904
2020
Q2 		$2.66M Buy
+2,628
New +$2.44M 0.05% 630
2020
Q1 		– Sell
-1,522
Closed -$1.63M – 2242
2019
Q4 		$1.63M Buy
1,522
+836
+122% +$853K 0.03% 861
2019
Q3 		$634K Buy
+686
New +$753K 0.01% 1180
2018
Q3 		– Sell
-152
Closed -$238K – 1947
2018
Q2 		$238K Sell
152
-410
-73% -$534K 0.01% 1230
2018
Q1 		$649K Buy
+562
New +$740K 0.04% 654
2017
Q3 		– Sell
-431
Closed -$348K – 1882
2017
Q2 		$348K Buy
+431
New +$300K 0.02% 943
2016
Q1 		– Sell
-941
Closed -$717K – 1679
2015
Q4 		$717K Buy
+941
New +$624K 0.04% 637
2015
Q3 		– Sell
-2,254
Closed -$1.32M – 1898
2015
Q2 		$1.32M Buy
2,254
+1,784
+380% +$1.04M 0.06% 424
2015
Q1 		$369K Buy
470
+132
+39% +$102K 0.02% 1127
2014
Q4 		$231K Buy
+338
New +$217K 0.01% 1411

Other funds holding KYNB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
GC
GFG Capital Miami, Florida $363M AUM 45.53% 1-Year Est. Return

Cubist Systematic Strategies's KYNB Position: Q3 2024 in Review

Cubist Systematic Strategies sold out of Kyntra Bio (KYNB) in Q3 2024, closing a stake of 11,493 shares — an estimated $256K sold.

Cubist Systematic Strategies first reported a position in KYNB in Q4 2014 and held it in 23 quarters. The position peaked at $2.66M in Q2 2020. 70 funds tracked by Wall St. Rank hold KYNB as of Q3 2024.

  • Cubist Systematic Strategies reported no remaining Kyntra Bio position as of Q3 2024 after selling out during the quarter.
  • Cubist Systematic Strategies sold 11,493 Kyntra Bio shares in Q3 2024, an estimated $256K.
  • Cubist Systematic Strategies first reported a position in Kyntra Bio in Q4 2014 and held it in 23 quarters.
  • Cubist Systematic Strategies's Kyntra Bio position peaked at $2.66M in Q2 2020.
  • 70 funds tracked by Wall St. Rank held Kyntra Bio as of Q3 2024.

Based on Cubist Systematic Strategies's 13F filing for Q3 2024, filed 14 Nov 2024.